Description

BPC-157 is a synthetic peptide composed of 15 amino acids, derived from a partial sequence of the naturally occurring body protection compound found in human gastric juice. It has gained attention in biomedical research due to its reported cytoprotective, angiogenic, and anti-inflammatory properties. The 250 mcg oral tablet form allows for convenient administration in controlled experimental environments.

Studies have investigated BPC-157’s potential to accelerate the healing of soft tissues such as muscles, tendons, ligaments, and even nerves. It is also frequently studied for its protective effects on the gastrointestinal tract, particularly in models of gastric ulceration, inflammatory bowel disease, and NSAID-induced damage. BPC-157 is believed to interact with the nitric oxide (NO) system and influence the expression of growth factors such as VEGF, contributing to tissue regeneration and repair. Despite its promising profile, BPC-157 remains an experimental compound not approved for clinical use.